Spring 2014 CAMCD Newsletter
Table of Contents
With the changing landscape of medical cannabis regulation in Canada, CAMCD reaffirms its commitment to patients, and the dispensaries that serve them.
We’ve seen sweeping changes across the nation in the medical cannabis industry, as a result of new federal regulations. This has also had an effect on dispensaries. With some parts of the country losing dispensaries as they close or transition to work with Licensed Producers, other parts of the country have seen explosive growth in the number of dispensaries opening. Both of these trends make the work CAMCD does even more important.
CAMCD recognizes that the dispensary model is preferred by patients and authorities in nearly all jurisdictions that regulate medical cannabis, and reaffirms its commitment to protect the integrity of this model as long as it is meeting the needs of patients in Canada.
To that end, we worked with lobbyists to consult closely with Health Canada as they developed the MMPR. We shared with them research and experience that indicates that patients need access to a variety a cannabis strains, as well as other cannabis products such as edibles and tinctures. We advocated for the continued right of patients to grow their own medicine, and for community-based distribution for those who were unable to do so. We also stressed the importance of opening up prescriptions to health practitioners beyond medical doctors. We shared the standards we have developed for dispensaries, and while we saw some of our recommendations in the MMPR, most of them were ignored.
As part of our mission to promote a regulated community-based approach to medical cannabis access and support medical cannabis dispensaries to provide the highest quality of patient care, CAMCD has developed a Certification Program. We want to see dispensaries integrated into the legal framework for medical cannabis in Canada, and self-regulation is needed as a first step towards being recognized for the work we do in our communities.
Currently, there are eight dispensaries in the process of becoming certified by CAMCD.
Click here for more information about our certification program.
CAMCD is pleased to announce the launch of a new service: the Canadian Dispensary Discussion List.
Through this list dispensaries will have access to a network representing decades of combined experience in dispensary operations in Canada. This list is intended to allow dispensaries to discuss topics of importance together, share resources, coordinate our efforts and have a stronger and more unified voice.
While only certified dispensaries can be an official member of CAMCD and sit on its Board of Directors, discussions and points raised on the list will all be considered in the CAMCD decision-making process.
Registration for the list is now open. Sign up here.
The Canadian Association of Medical Cannabis Dispensaries is pleased to be collaborator on the CANARY study.
This nation-wide study is examining the impact of changes to Health Canada’s medical marihuana program on the way patients access medical cannabis in Canada.
Individuals with any medical condition, regardless if they use cannabis, are eligible to participate in the study.
Participation in the CANARY Study involves the completion of 4 online surveys, taking 30 minutes each over a 15 month time period, and some participants will be asked to take part in telephone interviews. All information collected is confidential.
The CANARY Study is lead by researchers at the University of British Columbia in collaboration with the British Columbia Ministry of Health, the Canadian Consortium for the Investigation of Cannabinoids and the Canadian AIDS Society. Other affiliated organizations include: Canadian Medical Association, Canadian Cancer Society, British Columbia Cancer Agency, Canadian Association of Medical Cannabis Dispensaries, Action Atlantic, Chronic Pain Association of Canada, and Canadian Pain Coalition.
More information and a link to the survey can be found at http://canarystudy.ca.
We encourage all dispensaries to share this study with the patients they serve!
Friday, March 28:
Cannabinoids in Clinical Practice: Navigating a New Landscape
8:30 am – 4:30 pm
Eaton Chelsea, Toronto ON
Tuesday April 1:
Day of Action
All-day Across Canada
Fight the MMPR
Parliament of Canada, 111 Wellington Street, Ottawa ON
Saturday, April 5 – Monday, April 7:
National Medical Cannabis Unity Conference
Hosted by Americans for Safe Access
Thursday May 8- Saturday, May 10:
8th National Clinical Conference on Cannabis Therapeutics
Hosted by Patients out of Time
Saturday, June 28- Thursday, July 3
The 24th Annual International Cannabinoid Research Society Symposium
Lago Maggiore, Italy